Published in Hepatitis Weekly, October 2nd, 2006
"Human iNKT cells express a TCR V alpha 24-J alpha Q paired with V beta 11 and are activated by a surrogate ligand, alpha-galactosylceramide (alpha GalCer). The iNKT cells are involved in the regulation of antiviral immune responses; however, little is known about their roles in hepatitis C virus (HCV) infection," wrote M. Inoue and colleagues, Osaka University.
The authors continued, "We compared the frequency of peripheral iNKT cells and their cytokine producing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.